This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunome, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Anne Ye
Introduction
Anne Ye is a prominent inventor based in San Carlos, CA (US). She has made significant strides in the field of biotechnology, particularly with her work on EphA2 antibodies. Her innovative approach has the potential to impact cancer treatment and immunotherapy.
Latest Patents
Anne Ye holds a patent for EphA2 antibodies. These antibodies are designed to bind preferentially to tumor tissue rather than normal tissue, specifically targeting EphA2. The applications of these antibodies include methods for inducing an immune response and inhibiting tumor cell growth. Additionally, she has provided methods for producing such antibodies, showcasing her commitment to advancing medical science.
Career Highlights
Anne Ye is associated with Immunome, Inc., where she continues to develop her groundbreaking work. Her contributions to the field of immunology and cancer research are noteworthy, as they pave the way for new therapeutic strategies.
Collaborations
Some of her notable coworkers include Iraz T Aydin and Philippe Marguet. Their collaborative efforts contribute to the innovative environment at Immunome, Inc., fostering advancements in biotechnology.
Conclusion
Anne Ye's work exemplifies the spirit of innovation in the field of biotechnology. Her contributions, particularly in the development of EphA2 antibodies, hold promise for future cancer therapies.